DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Biopharma (1937)

Category

1937 Biopharma Reports

The financial burden of providing healthcare and the rising cost of the most...
The financial burden of providing healthcare and the rising cost of the most innovative medicines have pressured government healthcare budgets and highlight the need for payers to operate under a disc......
Type 2 diabetes is a complex metabolic disorder characterized by a declining...
Type 2 diabetes is a complex metabolic disorder characterized by a declining ability to produce or utilize insulin. The chronic and progressive nature of the disease, as well as its complications a......
Chronic kidney disease (CKD) affects approximately 26 million people in the...
Chronic kidney disease (CKD) affects approximately 26 million people in the United States. While there are multiple prescription therapies that are available for treating the associated symptoms, n......
Gastric cancer is the fourth-most common malignancy in terms of incidence and is...
Gastric cancer is the fourth-most common malignancy in terms of incidence and is the third-most common cause of cancer-related death worldwide. Japan has the highest incidence of gastric cancer amo......
Last Updated 16 September 2014 Owing to its large population, the treatment of...
Last Updated 16 September 2014 Owing to its large population, the treatment of breast cancer remains an active area of research with a rich and diverse product pipeline. A competitiv......
The number of diagnosed acute heart failure (AHF) events and prevalent chronic...
The number of diagnosed acute heart failure (AHF) events and prevalent chronic heart failure (CHF) cases in the seven major markets that we cover is increasing annually, driven by changes in the po......
Gram-negative infections (GNIs) represent a high-value segment of the antibiotic...
Gram-negative infections (GNIs) represent a high-value segment of the antibiotic market and are often treated in the hospital setting. Infections due to Gram-negative pathogens (GNPs) are frequentl......
1741 - 1760 of 1937